Only a limited number of studies have found a correlation between expression of LIG4, XRCC4, or XLF and cancer progression and patient outcomes, but a couple of studies have found that increased expression of these factors results in increased aggressiveness in tumors. This evidence concerns the gene LIG4 and cancer.